Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

eisa0008_web

Scottish Medicines Consortium recommends Eisai’s Kisplyx for advanced kidney cancer

November 12, 2019 Manufacturing and Production, Sales and Marketing Eisai, Kisplyx, NHS, Sotland, pharma

Eisai’s Kisplyx (lenvatinib) has secured recommendation from the Scottish Medicines Consortium, it has been revealed, meaning that patients on the …
News
msd

MSD secures EU approval for its Zaire Ebola vaccine Ervebo

November 12, 2019 Manufacturing and Production, Sales and Marketing Ebola, Ervebo, MSD, pharma

MSD has scored approval from the European Commission for Ervebo, the company’s Zaire Ebola vaccine, for the prevention of Ebola …
News

Novartis’ Kisqali approved for NHS Scotland in most common advanced breast cancer

November 12, 2019 Manufacturing and Production, Sales and Marketing Cancer, Kisqali, NHS, Novartis, Scotland, breast cancer, pharma

NHS patients in Scotland will soon be able to access Novartis’ CDK4/6 inhibitor Kisqali (ribociclib) after the Scottish Medicines Consortium …
News
funk

Lonza CEO to step down in 2020

November 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lonza, appointment

It has been announced that Marc Funk, Chief Executive Officer at Lonza, is set to step down from the role …
News

Working Life Interview: Alison Muir, Oncology Product Strategy Director at Roche

November 11, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, Working Life, feature, pharma

You studied biology at Liverpool John Moores University before heading straight to GSK in 1990 as a Sales Representative; was …
Feature
https__cdn

NHS to utilise first-ever cannabis-based therapies following NICE recommendation of two GW Pharma drugs

November 11, 2019 Sales and Marketing Epidyolex, GW Pharma, NHS, Sativex, pharma

The NHS is authorised to use its first two cannabis-based medicines for routine use after NICE saw fit to recommend …
News
roche

Roche’s risdiplam hits main goal in spinal muscular atrophy type 2 or 3

November 11, 2019 Research and Development, Sales and Marketing Roche, pharma, risdiplam, spinal muscular atrophy

Roche has lifted the curtain on new data which shows that its investigational survival motor neuron-2 (SMN2) splicing modifier risdiplam …
News
novartis_window

Novartis reveals strong Phase 2b data for tropifexor in non-alcoholic steatohepatitis

November 11, 2019 Research and Development, Sales and Marketing Novartis, nash, non-alcoholic steatohepatitis, pharma

The latest findings have been revealed from the final stage of Novartis’ Phase 2b evaluation of its non-bile acid FXR …
News
shutter

AnaptysBio’s etokimab fails in moderate-to-severe atopic dermatitis

November 11, 2019 Sales and Marketing AnaptysBio; atopic dermatitis, pharma

AnaptysBio has announced disappointing new Phase 2b data for its anti-IL-33 candidate etokimab in the treatment of moderate-to-severe atopic dermatitis. …
News

Celgene and Acceleron’s Reblozyl secures FDA approval for anaemia in beta thalassaemia

November 11, 2019 Sales and Marketing Acceleron, Celgene, Reblozyl, beta thalassaemia, pharma

The FDA has moved to authorise Celgene and Acceleron Pharma’s Reblozyl (luspatercept-aamt) in the treatment of anaemia associated with the …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

November 8, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

In our rundown of the week’s most popular stories, President Donald Trump has named his first choice for the top …
News
johnson_and_johnson_jj_4

J&J to supply 500,000 Ebola vaccines to fight DR Congo outbreak

November 7, 2019 Manufacturing and Production, Research and Development, Sales and Marketing Ebola, Janssen, Johnson & Johnson, pharma

Johnson & Johnson has reached an agreement with the Government of the Democratic Republic of the Congo (DRC) to supply …
News
astrazeneca_plaque_42

AstraZeneca reveals three-pronged “large-scale” R&D initiatives in China

November 7, 2019 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, China

AstraZeneca has doubled down on its commitment to the Chinese region with the announcement of three “large-scale initiatives” in the …
News
biogen_austria_238_29

Biogen scoops up eye and anti-TNF drug rights from Samsung Bioepis in $300m deal

November 7, 2019 Sales and Marketing Biogen, Samsung Bioepis, pharma

Biogen has struck a new deal with Samsung Bioepis, it has emerged, picking up the commercialisation rights to a raft …
News
paul-campanelli

Endo President and CEO to retire, search for a successor begins

November 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Endo pharma, appointment

Endo International has announced its “CEO succession plan”, revealing that the company’s Chief Executive and President Paul V Campanelli has …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025